AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-PREPACKAGED SOFTWARE
BIO-key International, Inc. Common Stock
XNAS · usd
SIC 7372 · SERVICES-PREPACKAGED SOFTWARE
FIGI BBG001S7ZTY2
3.39▲ 0.65 (23.72%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
2.74
Day's Range
3.21 – 3.92
52-Week Range
0.46 – 5.76
Volume
35.1M
Avg Volume
10.8M
Share Statistics
Shares Outstanding
Employees
52
Exchange
XNAS
Listed
1997-02-24
Share count as of August 11, 2026

BIO-key International, Inc. Common Stock (BKYI) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about BIO-key International, Inc. Common Stock (BKYI)
What is BIO-key International, Inc. Common Stock's Market Cap?
BIO-key International, Inc. Common Stock's Market Cap is $4.9M, based on as-reported figures from SEC (XBRL) filings.
What is BIO-key International, Inc. Common Stock's Price / Sales?
BIO-key International, Inc. Common Stock's Price / Sales is 0.7×, based on as-reported figures from SEC (XBRL) filings.
What is BIO-key International, Inc. Common Stock's Revenue (TTM)?
BIO-key International, Inc. Common Stock's Revenue (TTM) is $6.7M, based on as-reported figures from SEC (XBRL) filings.
What is BIO-key International, Inc. Common Stock's Net Income (TTM)?
BIO-key International, Inc. Common Stock's Net Income (TTM) is -$6.0M, based on as-reported figures from SEC (XBRL) filings.
What is BIO-key International, Inc. Common Stock's EBITDA?
BIO-key International, Inc. Common Stock's EBITDA is -$5.7M, based on as-reported figures from SEC (XBRL) filings.
What is BIO-key International, Inc. Common Stock's Diluted EPS (TTM)?
BIO-key International, Inc. Common Stock's Diluted EPS (TTM) is -4.20, based on as-reported figures from SEC (XBRL) filings.
What is BIO-key International, Inc. Common Stock's EBITDA Margin?
BIO-key International, Inc. Common Stock's EBITDA Margin is -85.2%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BKYIAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues
Revenues
YoY growth+13.1%+33.5%-25.9%-27.7%
Costs and other expenses
Cost of Goods and Services Sold
Gross profit
% of revenue87.2%82.5%75.0%76.9%
Operating expenses
Selling, general and administrative
Research, development and engineering
Total operating expenses
% of revenue114.8%89.8%463.5%134.5%
Operating loss
% of revenue-27.6%-7.4%-388.5%-57.6%
Other income (expense)
Interest income
Loan fee amortization
Interest expense
Total other income (expense), net
Loss before provision for income tax
Provision for income taxes
Net loss
% of revenue-30.0%-9.6%-395.8%-62.3%
Net loss
% of revenue-30.0%-9.6%-395.8%-62.3%
Basic and diluted loss per common share (in dollars per share)—